Apexigen (APGN) currently reports a operating income of $-28M as of June 2023. That compares with $-1.8B in the prior-year period — up 98.5% year over year. Use the charts on this page to explore Apexigen's operating income history and peer comparisons.

Apexigen's operating income increased from $-1.8B to $-28M — a 98.5% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Apexigen reported $-28M in operating income as of June 2023. That compares with $-1.8B in the prior-year period — up 98.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-28M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Apexigen, and consider following APGN for alerts when major investors trade the stock.